Skip to main content
Premium Trial:

Request an Annual Quote

Diagnos Teams with Univ. of Queens for Follicular Lymphoma Dx

NEW YORK (GenomeWeb News) – Canadian data extraction specialty company Diagnos will partner with Ontario’s University of Queens to develop a biomarker-based test and a new algorithm to help doctors diagnose follicular lymphoma, the company said today.
Under the first phase of the project, the company will work with the University of Queens’ Cancer Research Institute to develop an automated approach for distinguishing follicular lymphoma from benign lymphoid infiltrates using small samples. The company said it plans to increase its accuracy by using morphological analysis along with immunohistochemistry.
In the second phase of research, the company will use its data extraction technologies to find protein or nucleic acid biomarkers that can be used to better diagnose and predict treatment for this type of lymphoma.
The company said it selected follicular lymphoma because it currently is a difficult subtype to diagnose with accuracy and confidence.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.